Tech Company Financing Transactions
Curamir Therapeutics Funding Round
On 9/24/2019, Curamir Therapeutics received $10 million in Series A financing from Delos Capital.
Transaction Overview
Company Name
Announced On
9/24/2019
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Delos Capital (Henry Chen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 G Gill St.
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Email Address
Not Recorded
Overview
Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Henry Chen
Browse more venture capital transactions:
Prev: 9/24/2019: Immutable venture capital transaction
Next: 9/24/2019: GroGuru venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs